Skip to content
PoliticalRepoPoliticalRepo

United Kingdom · Motion · Early Day Motion

EDM 867

RESEARCH AND DEVELOPMENT AND NEW MEDICINES

openUnited Kingdom· UK Parliament· EN

Introduced

14 December 2015

Last action

14 December 2015 · Early Day Motion

Status

0

Sponsors

Sir Alan Meale

Subjects

Discovery layer

Source updated

14 December 2015

Summary

That this House is aware that the World Health Organisation (WHO) is shortly to discuss reforms of the research and development of medicines worldwide; notes that examples of failures in medicine include lack of new treatments for conditions such as tuberculosis and other so-called diseases of poverty, and that those suffering life threatening conditions like cancer being unable to afford the treatments needed to survive; and further notes the WHO has created a consultative export group (CEG) whose remit is to prepare a new international agreement which will create alternatives to market-only based incentives for pharmaceutical companies to produce new medicines, prioritise health research according to need rather than profit and establish a pooled fund for research and development to be financed by a levy of 0.01 per cent of gross domestic product to develop new treatments.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 December 2015

    Early Day Motion

    That this House is aware that the World Health Organisation (WHO) is shortly to discuss reforms of the research and development of medicines worldwide; notes that examples of failures in medicine include lack of new treatments for conditions such as tuberculosis and other so-called diseases of poverty, and that those suffering life threatening conditions like cancer being unable to afford the treatments needed to survive; and further notes the WHO has created a consultative export group (CEG) whose remit is to prepare a new international agreement which will create alternatives to market-only based incentives for pharmaceutical companies to produce new medicines, prioritise health research according to need rather than profit and establish a pooled fund for research and development to be financed by a levy of 0.01 per cent of gross domestic product to develop new treatments.

    Source: Early Day Motion

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.